Singular Health Group (ASX:SHG) YoY EPS Growth: 26.67% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:SHG Singular Health Group Ltd ASX:SHG
22 GF Score
Price A$0.18
GF Value A$0.11
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Singular Health Group YoY EPS Growth?

Singular Health Group ASX:SHG -5.26% 22 YoY EPS Growth is 26.67% as of Jun. 2026. GuruFocus rates ASX:SHG with a GF Score™ of 22/100 and a GF Value™ of A$0.11 (Significantly Overvalued). The stock has 2 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Singular Health Group's YoY EPS Growth for the quarter that ended in Jun. 2026 was 26.67%.

Singular Health Group's Earnings per Share (Diluted) for the six months ended in Jun. 2026 was A$-0.01.

Singular Health Group YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Singular Health Group's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singular Health Group YoY EPS Growth Chart

Singular Health Group Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
YoY EPS Growth
Get a 7-Day Free Trial 3.33 25.86 27.91 12.90 25.93

Singular Health Group Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -64.29 -62.50 34.78 23.08 26.67
ASX:SHG
22GF Score
Singular Health Group Ltd ASX:SHG
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Singular Health Group YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Singular Health Group's YoY EPS Growth for the fiscal year that ended in Jun. 2026 is calculated as:

YoY EPS Growth (A: Jun. 2026 )
=(Earnings per Share (Diluted) (A: Jun. 2026 )-Earnings per Share (Diluted) (A: Jun. 2025 ))/ | Earnings per Share (Diluted) (A: Jun. 2025 ) |
=(-0.02--0.027)/ | -0.027 |
=25.93 %

Singular Health Group's YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Jun. 2025 )) / | Earnings per Share (Diluted) (Q: Jun. 2025 )) |
=(-0.011--0.015)/ | -0.015 |
=26.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 26.67% mean?
Singular Health Group (ASX:SHG) has a YoY EPS Growth of 26.67% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Singular Health Group and its competitors.
Is Singular Health Group's YoY EPS Growth too high?
Singular Health Group's current YoY EPS Growth is 26.67%. Overall, Singular Health Group has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Singular Health Group's YoY EPS Growth compare to VEEV and BTSG?
Singular Health Group's YoY EPS Growth of 26.67% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Healthcare Providers & Services company?
A good YoY EPS Growth depends on the Healthcare Providers & Services industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Singular Health Group and its competitors. Singular Health Group's current YoY EPS Growth is 26.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singular Health Group stock overvalued right now?
Based on GuruFocus' analysis, Singular Health Group (ASX:SHG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.11, compared to a current price of A$0.18 — trading 63.6% above its estimated fair value. The current YoY EPS Growth is 26.67%. Singular Health Group's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Singular Health Group (ASX:SHG), the current YoY EPS Growth is 26.67% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Singular Health Group (ASX:SHG) Overvalued in 2026?

Based on GuruFocus' analysis, Singular Health Group stock appears to be overvalued. The current stock price of A$0.18 is trading 63.6% above its estimated GF Value™ of A$0.11. GuruFocus considers Singular Health Group to be Significantly Overvalued.

Key valuation signals for ASX:SHG:

  • YoY EPS Growth: 26.67%
  • GF Value™: A$0.11 vs. price of A$0.18 (63.6% above fair value)
  • GF Score™: 22/100 with 2 warning signs

No single metric tells the full story. See the ASX:SHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Singular Health Group Business Description

Address E3 and E4, 661 Newcastle Street, Leederville, WA, AUS, 6007
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.
22GF Score

Get the complete analysis for ASX:SHG

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.18
Price
A$0.11
GF Value